These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7266363

  • 1. Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
    Reeve J, Arlot M, Bernat M, Charhon S, Edouard C, Slovik D, Vismans FJ, Meunier PJ.
    Metab Bone Dis Relat Res; 1981; 3(1):23-30. PubMed ID: 7266363
    [No Abstract] [Full Text] [Related]

  • 2. Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
    Reeve J, Arlot M, Price TR, Edouard C, Hesp R, Hulme P, Ashby JP, Zanelli JM, Green JR, Tellez M.
    Eur J Clin Invest; 1987 Oct; 17(5):421-8. PubMed ID: 3121346
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.
    Slovik DM, Neer RM, Potts JT.
    J Clin Invest; 1981 Nov; 68(5):1261-71. PubMed ID: 7298851
    [Abstract] [Full Text] [Related]

  • 6. The turnover time of calcium in the exchangeable pools of bone in man and the long-term effect of a parathyroid hormone fragment.
    Reeve J.
    Clin Endocrinol (Oxf); 1978 Jun; 8(6):445-55. PubMed ID: 668151
    [Abstract] [Full Text] [Related]

  • 7. Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover.
    Hesch RD, Heck J, Delling G, Keck E, Reeve J, Canzler H, Schober O, Harms H, Rittinghaus EF.
    Klin Wochenschr; 1988 Oct 03; 66(19):976-84. PubMed ID: 3141672
    [Abstract] [Full Text] [Related]

  • 8. Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients.
    Hodsman AB, Fraher LJ.
    Bone Miner; 1990 May 03; 9(2):137-52. PubMed ID: 2161692
    [Abstract] [Full Text] [Related]

  • 9. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone.
    Liu CC, Kalu DN, Salerno E, Echon R, Hollis BW, Ray M.
    J Bone Miner Res; 1991 Oct 03; 6(10):1071-80. PubMed ID: 1796755
    [Abstract] [Full Text] [Related]

  • 10. [Morphologic study of iliac crest spongiosa in patients with osteoporosis treated according to the ADFR (activation, depression of resorption, formation, repeat the cycle) with parathyroid hormone and diphosphonates (Hannover PTH I study)].
    Delling G, Dreyer T, Hahn M, Vogel M, Rittinghaus EF, Hesch RD.
    Z Orthop Ihre Grenzgeb; 1990 Oct 03; 128(1):1-5. PubMed ID: 2138378
    [Abstract] [Full Text] [Related]

  • 11. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP, Johnson CS, Vafai HT, Kaplan KC, Bailey J, Capwell B, Fraser F, Hansen L, Ramsay H, Shadoan M, Lees CJ, Thomsen JS, Mosekilde L.
    Bone; 1999 Sep 03; 25(3):301-9. PubMed ID: 10495134
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
    Cosman F, Nieves J, Woelfert L, Formica C, Gordon S, Shen V, Lindsay R.
    J Bone Miner Res; 2001 May 03; 16(5):925-31. PubMed ID: 11341338
    [Abstract] [Full Text] [Related]

  • 13. Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis.
    Whitfield JF, Morley P.
    Trends Pharmacol Sci; 1995 Nov 03; 16(11):382-6. PubMed ID: 8578607
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone.
    Bradbeer JN, Arlot ME, Meunier PJ, Reeve J.
    Clin Endocrinol (Oxf); 1992 Sep 03; 37(3):282-9. PubMed ID: 1424211
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human parathyroid hormone (PTH)-related protein and human PTH: comparative biological activities on human bone cells and bone resorption.
    Fukayama S, Bosma TJ, Goad DL, Voelkel EF, Tashjian AH.
    Endocrinology; 1988 Dec 03; 123(6):2841-8. PubMed ID: 2848688
    [Abstract] [Full Text] [Related]

  • 18. Coupled bone metabolism in vitro: embryonic chick limbs in organ culture.
    Howard GA, Carlson CA, Baylink DJ.
    Prog Clin Biol Res; 1982 Dec 03; 101():259-74. PubMed ID: 7156141
    [No Abstract] [Full Text] [Related]

  • 19. Pathological and therapeutic implications of the cellular and humoral responses to parathyrin.
    Parsons JA, Meunier P, Podbesek R, Reeve J, Stevenson RW.
    Biochem Soc Trans; 1981 Oct 03; 9(5):383-6. PubMed ID: 7026314
    [No Abstract] [Full Text] [Related]

  • 20. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.
    Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OL, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJ, Potts JT.
    Br Med J; 1980 Jun 07; 280(6228):1340-4. PubMed ID: 6992932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.